Biologics

October 2012
- Friday 05
  - Possession, Use, and Transfer of Select Agents and Toxins; Biennial Review
August 2012
- Monday 06
  - Changes To Implement Miscellaneous Post Patent Provisions of the Leahy-Smith America Invents Act
July 2012
- Tuesday 17
  - Changes To Implement the Preissuance Submissions by Third Parties Provision of the Leahy-Smith America Invents Act
May 2012
- Thursday 03
  - Amendments to Sterility Test Requirements for Biological Products
June 2011
- Tuesday 21
  - Amendments to Sterility Test Requirements for Biological Products
March 2010
- Tuesday 30
  - Revision of the Requirements for Constituent Materials
August 2009
- Tuesday 25
  - Microbiology Devices; Reclassification of Herpes Simplex Virus Types 1 and 2 Serological Assays
- Wednesday 19
  - Possession, Use, and Transfer of Select Agents and Toxins-Chapare virus
July 2009
- Monday 13
  - Possession, Use, and Transfer of Select Agents and Toxins; Proposed Addition of SARS-Associated Coronavirus (SARS-CoV)
October 2008
- Thursday 30
  - Possession, Use, and Transfer of Select Agents and Toxins
- Thursday 16
  - Possession, Use, and Transfer of Select Agents and Toxins
- Thursday 09
  - National Vaccine Injury Compensation Program: Removal of Separate Category for Vaccines Containing Live, Oral, Rhesus-Based Rotavirus From the Vaccine Injury Table
January 2008
- Wednesday 23
  - Interstate Shipment of Etiologic Agents
October 2007
- Thursday 18
  - Revision of the Requirements for Live Vaccine Processing
August 2007
- Tuesday 28
  - Possession, Use, and Transfer of Select Agents and Toxins
- Wednesday 22
  - Revision of Patent Fees for Fiscal Year 2007
July 2007
- Thursday 05
  - National Vaccine Injury Compensation Program: Calculation of Average Cost of a Health Insurance Policy
May 2007
- Wednesday 09
  - Medical Devices; Immunology and Microbiology Devices; Classification of Gene Expression Profiling Test System for Breast Cancer Prognosis
April 2007
- Monday 16
  - Revisions and Technical Corrections Affecting Requirements for Ex Parte
March 2007
- Monday 12
  - Blood Vessels Recovered With Organs and Intended for Use in Organ Transplantation
January 2007
- Tuesday 16
  - Changes to Implement Priority Document Exchange Between Intellectual Property Offices
- Wednesday 10
  - Medical Devices; Immunology and Microbiology Devices; Classification of Quality Control Material for Cystic Fibrosis Nucleic Acid Assays
- Wednesday 03
  - Interstate Shipment of Etiologic Agents
December 2006
- Friday 08
  - The Biological Defense Safety Program and Technical Safety Requirements
August 2006
- Friday 04
  - Clarification of Filing Date Requirements for Ex Parte
June 2006
- Monday 05
  - Revision of Patent Fees for Fiscal Year 2007
May 2006
- Wednesday 24
  - Smallpox Vaccine Injury Compensation Program: Smallpox (Vaccinia) Vaccine Injury Table
  - Smallpox Vaccine Injury Compensation Program: Administrative Implementation
March 2006
- Thursday 30
  - Revisions and Technical Corrections Affecting Requirements for Ex Parte
February 2006
- Thursday 23
  - Clarification of Filing Date Requirements for Ex Parte and Inter Partes Reexamination Proceedings
October 2005
- Thursday 20
  - Possession, Use, and Transfer of Select Agents and Toxins-Reconstructed Replication Competent Forms of the 1918 Pandemic Influenza Virus Containing Any Portion of the Coding Regions of All Eight Gene Segments
March 2005
- Friday 18
  - Possession, Use, and Transfer of Select Agents and Toxins
September 2004
- Thursday 30
  - Rules of Practice Before the Board of Patent Appeals and Interferences
August 2004
- Thursday 12
  - Rules of Practice Before the Board of Patent Appeals and Interferences
December 2003
- Tuesday 16
  - Smallpox Vaccine Injury Compensation Program: Administrative Implementation
November 2003
- Wednesday 26
  - Rules of Practice Before the Board of Patent Appeals and Interferences
- Monday 03
  - Possession, Use, and Transfer of Select Agents and Toxins
August 2003
- Wednesday 27
  - Smallpox Vaccine Injury Compensation Program: Smallpox (Vaccinia) Vaccine Injury Table
December 2002
- Friday 13
  - Possession, Use, and Transfer of Select Agents and Toxins
July 2002
- Thursday 25
  - National Vaccine Injury Compensation Program: Revisions and Additions to the Vaccine Injury Table
January 2002
- Monday 14
  - Hematology and Pathology Devices; Reclassification of the Automated Differential Cell Counter
August 2001
- Friday 31
  - Requirements for Facilities Transferring or Receiving Select Agents
July 2001
- Friday 13
  - National Vaccine Injury Compensation Program: Revisions and Additions to the Vaccine Injury Table
December 2000
- Tuesday 12
  - Revision to Requirements for Licensed Anti-Human Globulin and Blood Grouping Reagents
  - Revision to Requirements for Licensed Anti-Human Globulin and Blood Grouping Reagents; Companion to Direct Final Rule
November 2000
- Wednesday 22
  - Immunology and Microbiology Devices; Classification of Anti-Saccharomyces cerevisiae (S. cerevisiae) Antibody (ASCA) Test Systems
- Tuesday 07
  - Biological Products: Reporting of Biological Product Deviations in Manufacturing
October 2000
- Friday 06
  - Regulations Requiring Manufacturers to Assess the Safety and Effectiveness of New Drugs and Biological Products in Pediatric Patients; Technical Amendment

Rules of Practice Before the Board of Patent Appeals and Interferences
08/12/2004; 7 citations
Possession, Use, and Transfer of Select Agents and Toxins
03/18/2005; 4 citations
Smallpox Vaccine Injury Compensation Program: Administrative Implementation
12/16/2003; 2 citations
Possession, Use, and Transfer of Select Agents and Toxins; Biennial Review
10/05/2012; 1 citation
Interstate Shipment of Etiologic Agents
01/03/2007; 1 citation
Revision of Patent Fees for Fiscal Year 2007
06/05/2006; 1 citation
Rules of Practice Before the Board of Patent Appeals and Interferences
11/26/2003; 1 citation

Loading most recent entries

Feedback